logo
Plus   Neg
Share
Email

Janssen: CHMP Recommends Expanded Use Of SPRAVATO - Quick Facts

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the expanded use of SPRAVATO for the rapid reduction of depressive symptoms in a psychiatric emergency for patients with major depressive disorder. The European marketing authorisation application was based on the phase 3 double-blind, randomised, placebo controlled, multicentre ASPIRE I & II clinical studies conducted across Europe.

Esketamine nasal spray was approved by the European Commission for use in combination with a selective serotonin reuptake inhibitor or serotonin and norepinephrine reuptake inhibitor, in adult patients with treatment-resistant major depressive disorder in December 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. recalled about 15,800 units of Off-Road and Utility Vehicles in North America for possible crash hazard, according to a statement issued by the U.S. Consumer Product Safety Commission. There were also an additional 711 units sold in Canada. AstraZeneca's efforts to supply Covid-19 vaccine doses from its Italian unit to Australia has been blocked by the European Union and the Italian Government, citing Australia being non-vulnerable region and delays in domestic supply, among others. Italy's proposal to deny AstraZeneca's request for authorization to export COVID-19 vaccines was subsequently approved by the European Commission. Chipotle Mexican Grill, Inc. is teaming with e.l.f. Cosmetics to launch a limited edition beauty collection on March 10, aiming to support plant-based lifestyles and responsibly-sourced products. The e.l.f. x Chipotle makeup collection will comprise cruelty-free and vegan products inspired by Chipotle's responsibly-raised food.
Follow RTT